Chemical genomics-based drug discovery platform
Infinity is a clinical-stage company focused on developing new medicines for the treatment of cancer.
Advent invested in 2002. Infinity listed in 2009 (NASDAQ:INFI).
Chemical genomics-based drug discovery platform
Infinity is a clinical-stage company focused on developing new medicines for the treatment of cancer.
Advent invested in 2002. Infinity listed in 2009 (NASDAQ:INFI).